A Oliver Sartor (Oliver Sartor)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 43

Top Topics

Prostate Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Scott T Tagawa, Charlene Thomas, A Oliver Sartor, Michael Sun, Judith Stangl-Kremser, Mahelia Bissassar, Shankar Vallabhajosula, Sandra Huicochea Castellanos, Jones T Nauseef, Cora N Sternberg, Ana Molina, Karla V Ballman, David M Nanus, Joseph R Osborne, Neil H Bander
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225 Ac-J591. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
A Oliver Sartor
Radium-223 and bone metastatic disease: still more to learn. JNCI cancer spectrum 7 (6) (2023)
Albert Jang, Sree M Lanka, Minqi Huang, Crystal V Casado, Sydney A Caputo, Patrick L Sweeney, Kanika Gupta, Olivia Pocha, Nicholas Habibian, Madeline E Hawkins, Alexandra D Lieberman, Jennifer Schwartz, Ellen B Jaeger, Patrick J Miller, Jodi L Layton, Pedro C Barata, Brian E Lewis, Elisa M Ledet, A Oliver Sartor
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide. The Prostate (2023)
A Oliver Sartor
Localized Prostate Cancer - Then and Now. The New England journal of medicine (2023)
Sydney A Caputo, Madeline Hawkins, Ellen B Jaeger, William Fleming, Crystal Casado, Charlotte Manogue, Minqi Huang, Alex Lieberman, Malcolm Light, Isabelle P Sussman, Patrick Miller, Pedro C Barata, Brian E Lewis, Jodi Lyn Layton, Elisa M Ledet, Emmanuel S Antonarakis, A Oliver Sartor
Clinical and Molecular Determinants of PSA Response to Bipolar Androgen Therapy in Prostate Cancer. The Prostate (2023)
A Oliver Sartor
Circulating Tumor DNA Biomarkers for Response Assessment in Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
A Oliver Sartor
Circulating tumor DNA biomarkers for response assessment in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Albert Jang, Sree M Lanka, Ellen B Jaeger, Alexandra Lieberman, Minqi Huang, A Oliver Sartor, Prateek Mendiratta, Jason R Brown, Jorge A Garcia, Tiffany Farmer, Sumedha Sudhaman, Tamara Mahmood, Natalia Pajak, Mark Calhoun, Punashi Dutta, Adam ElNaggar, Minetta C Liu, Pedro C Barata
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies. JCO precision oncology 7 (2023)
A Oliver Sartor, Albert Jang, Elisa Ledet
Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer. The oncologist (2023)
Zachary Quinn, Benjamin E Leiby, Guru P Sonpavde, Atish D Choudhury, Christopher J Sweeney, David J Einstein, Russell Z Szmulewitz, A Oliver Sartor, Beatrice Knudsen, Eddy Shih-Hsin Yang, William Kevin Kelly
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Daniel J George, Archana M Agarwal, A Oliver Sartor, Cora N Sternberg, Bertrand Tombal, Fred Saad, Kurt Miller, Niculae Constantinovici, Helen Guo, John Reeves, XiaoLong Jiao, Per Sandström, Frank Verholen, Celestia S Higano, Neal Shore
Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study). Prostate cancer and prostatic diseases 25 (2) (2022)
Daniel Sentana-Lledo, A Oliver Sartor, Steven P Balk, David J Einstein
Immune mechanisms behind prostate cancer in men of African ancestry: A review. The Prostate 82 (8) (2022)
Alex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, Ellen Jaeger, Elisa M Ledet, Ayse T Kendi, Katherine Tzou, Fernando Quevedo, Richard Choo, Cassandra N Moore, Thai H Ho, Parminder Singh, Sameer R Keole, William W Wong, A Oliver Sartor, Alan H Bryce
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate 82 (12) (2022)
Maha H A Hussain, Michael A Carducci, Noel Clarke, Sarah E Fenton, Karim Fizazi, Silke Gillessen Sommer, Heather Jacene, Michael J Morris, Fred Saad, A Oliver Sartor, Mary-Ellen Taplin, Neha Vapiwala, Scott G Williams, Christopher J Sweeney
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Christopher T Su, Emily Nizialek, Jacob E Berchuck, Panagiotis J Vlachostergios, Ryan Ashkar, Alexandra O Sokolova, Pedro C Barata, Rahul R Aggarwal, Rana R McKay, Neeraj Agarwal, Heather M McClure, Nellie N Nafissi, Alan H Bryce, A Oliver Sartor, Nicolas Sayegh, Heather H Cheng, Nabil Adra, Cora N Sternberg, Mary-Ellen Taplin, Marcin Cieslik, Ajjai S Alva, Emmanuel S Antonarakis
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer. The Prostate (2022)
Alexandra O Sokolova, Catherine H Marshall, Rebeca Lozano, Roman Gulati, Elisa M Ledet, Navonil De Sarkar, Petros Grivas, Celestia S Higano, Bruce Montgomery, Peter S Nelson, David Olmos, Vadim Sokolov, Michael T Schweizer, Todd A Yezefski, Evan Y Yu, Channing J Paller, A Oliver Sartor, Elena Castro, Emmanuel S Antonarakis, Heather H Cheng
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. The Prostate 81 (16) (2021)
A Oliver Sartor, Johann de Bono, Kim N Chi, Karim Fizazi, Ken Herrmann, Kambiz Rahbar, Scott T Tagawa, Luke T Nordquist, Nitin Vaishampayan, Ghassan El-Haddad, Chandler H Park, Tomasz M Beer, Alison Armour, Wendy J Pérez-Contreras, Michelle DeSilvio, Euloge Kpamegan, Germo Gericke, Richard A Messmann, Michael J Morris, Bernd J Krause, null null
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. The New England journal of medicine 385 (12) (2021)
Elisa M Ledet, A Oliver Sartor
Letter to the Editor: "Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients". The Prostate 81 (15) (2021)
A Oliver Sartor, Daniel J George, Bertrand Tombal, Archana M Agarwal, Celestia S Higano, Cora N Sternberg, Kurt Miller, XiaoLong Jiao, Helen Guo, Per Sandström, Amanda Bruno, Frank Verholen, Fred Saad, Neal D Shore
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC. Future oncology (London, England) 18 (1) (2021)
Wensheng Zhang, Yan Dong, A Oliver Sartor, Kun Zhang
Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis. Cancer prevention research (Philadelphia, Pa.) 14 (7) (2021)
Elisa M Ledet, Earle F Burgess, Alexandra O Sokolova, Ellen B Jaeger, Whitley Hatton, Marcus Moses, Patrick Miller, Patrick Cotogno, Jodi Layton, Pedro Barata, Brian E Lewis, Mari Nakazawa, Jason Zhu, Beth Dellinger, Sara Elrefai, Nellie N Nafissi, Jan B Egan, Neal Shore, Rana R McKay, Alan H Bryce, Heather H Cheng, Emmanuel S Antonarakis, A Oliver Sartor
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. The Prostate 81 (7) (2021)
Daniel E Spratt, Neal Shore, A Oliver Sartor, Dana Rathkopf, Kara Olivier
Treating the patient and not just the cancer: therapeutic burden in prostate cancer. Prostate cancer and prostatic diseases 24 (3) (2021)
Samuel R Denmeade, Hao Wang, Archana M Agarwal, David C Smith, Michael T Schweizer, Mark N Stein, Vasileios Assikis, Przemyslaw W Twardowski, Thomas W Flaig, Russell Z Szmulewitz, Jeffrey M Holzbeierlein, Ralph J Hauke, Guru P Sonpavde, Jorge A Garcia, Arif Hussain, A Oliver Sartor, Shifeng S Mao, Harry Cao, Wei Fu, Ting Wang, Rehab Abdallah, Su Jin Lim, Vanessa Cilento, Channing J Paller, Michael A Carducci, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Rachel A Sabol, Elisa M Ledet, Ellen Jaeger, Whitley Hatton, Marcus Moses, Anjali Lankford, Alexa Zaheria, Pedro Barata, Jodi L Layton, Brian E Lewis, A Oliver Sartor
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients. The Prostate 81 (7) (2021)
Catherine Handy Marshall, Wei Fu, Hao Wang, Jong Chul Park, Theodore L DeWeese, Phuoc T Tran, Daniel Y Song, Serina King, Michaella Afful, Julia Hurrelbrink, Charlotte Manogue, Patrick Cotogno, Nancy P Moldawer, Pedro C Barata, Charles G Drake, Edwin M Posadas, Andrew J Armstrong, A Oliver Sartor, Emmanuel S Antonarakis
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2021)
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H Cheng, Alexandra O Sokolova, Archana M Agarwal, Adam Kessel, Alan H Bryce, Nellie Nafissi, Pedro C Barata, A Oliver Sartor, Diogo Assed Bastos, Oren Smaletz, Jacob E Berchuck, Mary-Ellen Taplin, Rahul R Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Christopher T Su, Catherine Handy Marshall, Emmanuel S Antonarakis
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 5 (2021)
Daniel J George, Susan Halabi, Elisabeth I Heath, A Oliver Sartor, Guru P Sonpavde, Devika Das, Rhonda L Bitting, William Berry, Patrick Healy, Monika Anand, Carol Winters, Colleen Riggan, Julie Kephart, Rhonda Wilder, Kellie Shobe, Julia Rasmussen, Matthew I Milowsky, Mark T Fleming, James Bearden, Michael Goodman, Tian Zhang, Michael R Harrison, Megan McNamara, Dadong Zhang, Bonnie L LaCroix, Rick A Kittles, Brendon M Patierno, Alexander B Sibley, Steven R Patierno, Kouros Owzar, Terry Hyslop, Jennifer A Freedman, Andrew J Armstrong
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer 127 (16) (2021)
Lawrence Fong, Michael J Morris, A Oliver Sartor, Celestia S Higano, Lance Pagliaro, Ajjai Alva, Leonard J Appleman, Winston Tan, Ulka Vaishampayan, Raphaelle Porcu, Darren Tayama, Edward E Kadel, Kobe C Yuen, Asim Datye, Andrew J Armstrong, Daniel P Petrylak
A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Johann S de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, A Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Niven Mehra, Carsten Goessl, Jinyu Kang, Joseph Burgents, Wenting Wu, Alexander Kohlmann, Carrie A Adelman, Maha Hussain
Olaparib for Metastatic Castration-Resistant Prostate Cancer. The New England journal of medicine 382 (22) (2020)
Celestia S Higano, Andrew J Armstrong, A Oliver Sartor, Nicholas J Vogelzang, Philip W Kantoff, David G McLeod, Christopher M Pieczonka, David F Penson, Neal D Shore, Jeffrey Vacirca, Raoul S Concepcion, Ronald F Tutrone, Luke T Nordquist, David I Quinn, Vahan Kassabian, Mark C Scholz, Matt Harmon, Robert C Tyler, Nancy N Chang, Hong Tang, Matthew R Cooperberg
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data. Cancer 126 (12) (2020)
Emily N Risdon, Cindy H Chau, Douglas K Price, A Oliver Sartor, William Douglas Figg
PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA. The oncologist 26 (1) (2020)
Johann S de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, A Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Guilhem Roubaud, Mustafa Özgüroğlu, Jinyu Kang, Joseph Burgents, Christopher Gresty, Claire Corcoran, Carrie A Adelman, null null
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer. The New England journal of medicine 383 (24) (2020)
Pedro Barata, Elisa Ledet, Charlotte Manogue, Patrick Cotogno, Kendra Harris, Brian Lewis, Jodi Layton, A Oliver Sartor
Long-Term Disease Control Using Taxane/Platinum-Based Chemotherapy in CDK12-Mutated Advanced Prostate Cancer. The oncologist 25 (9) (2020)
Wensheng Zhang, Yan Dong, A Oliver Sartor, Erik K Flemington, Kun Zhang
SEER and Gene Expression Data Analysis Deciphers Racial Disparity Patterns in Prostate Cancer Mortality and the Public Health Implication. Scientific reports 10 (1) (2020)
Sen Liu, Fengli Liu, Bing Zhang, Peng Yan, Brian G Rowan, Asim B Abdel-Mageed, Chad Steele, S Michal Jazwinski, Krzysztof Moroz, Elizabeth B Norton, Alun Wang, Leann Myers, A Oliver Sartor, Qiuyang Zhang
CD4+ T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion. The Prostate 80 (10) (2020)
Neal Shore, Celestia S Higano, Daniel J George, Cora N Sternberg, Fred Saad, Bertrand Tombal, Kurt Miller, Jan Kalinovsky, XiaoLong Jiao, Krishna Tangirala, A Oliver Sartor
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases 23 (4) (2020)
Celestia S Higano, Andrew J Armstrong, A Oliver Sartor, Nicholas J Vogelzang, Philip W Kantoff, David G McLeod, Christopher M Pieczonka, David F Penson, Neal D Shore, Jeffrey Vacirca, Raoul S Concepcion, Ronald F Tutrone, Luke T Nordquist, David I Quinn, Vahan Kassabian, Mark C Scholz, Matt Harmon, Robert C Tyler, Nancy N Chang, Hong Tang, Matthew R Cooperberg
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer. Cancer 125 (23) (2019)
A Oliver Sartor, Daniel Heinrich, Neil Mariados, Maria José Méndez Vidal, Daniel Keizman, Camilla Thellenberg Karlsson, Avivit Peer, Giuseppe Procopio, Stephen J Frank, Kalevi Pulkkanen, Eli Rosenbaum, Stefano Severi, José Trigo, Lucia Trandafir, Volker Wagner, Rui Li, Luke T Nordquist
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases. The Prostate 79 (14) (2019)
Elisa M Ledet, Emmanuel S Antonarakis, William B Isaacs, Tamara L Lotan, Colin Pritchard, A Oliver Sartor
Germline BLM mutations and metastatic prostate cancer. The Prostate 80 (2) (2019)
Elisa M Ledet, Michael B Lilly, Guru Sonpavde, Edwin Lin, Roberto H Nussenzveig, Pedro C Barata, Mark Yandell, Rebecca J Nagy, Lesli Kiedrowski, Neeraj Agarwal, A Oliver Sartor
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer. The oncologist (2019)
Daniel P Petrylak, Nicholas J Vogelzang, Kamal Chatta, Mark T Fleming, David C Smith, Leonard J Appleman, Arif Hussain, Manuel Modiano, Parminder Singh, Scott T Tagawa, Ira Gore, Edward F McClay, Anthony E Mega, A Oliver Sartor, Bradley Somer, Raymond Wadlow, Neal D Shore, William C Olson, Nancy Stambler, Vincent A DiPippo, Robert J Israel
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study. The Prostate 80 (1) (2019)
A Oliver Sartor
Why is prostate cancer incidence rising in young men? Cancer 126 (1) (2019)
Elisa M Ledet, Michael B Lilly, Guru Sonpavde, Edwin Lin, Roberto H Nussenzveig, Pedro C Barata, Mark Yandell, Rebecca J Nagy, Lesli Kiedrowski, Neeraj Agarwal, A Oliver Sartor
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer. The oncologist 25 (4) (2019)